CSI Market
Sign In | Register

Bio rad Laboratories Inc (BIO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access BIO Annual Balance Sheets →
The balance sheet data below highlights changes in Bio rad Laboratories Inc's financial position over recent quarters.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BIO/balance-sheets
https://api.csimarket.com/api/v1/companies/BIO/fundamentals
https://api.csimarket.com/api/v1/companies/BIO/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Balance Sheet API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2026)
(Jun 30 2026) (Mar 31 2026) (Dec 31 2025) (Sep 30 2025)
Assets
Cash & cash equivalent465.30
Restricted Cash1.60
Short-term Investments, Total371.80
Cash & Short-term Investments836.00
Accounts receivable422.60
Notes Receivable, Current10.70
Inventories783.90
Other Current Assets0.00
Prepaid Expense, Current AS160.70
Total Current Assets3,078.60
Equipment/Property/Plant Net0.00
Goodwill net573.00
Intangible Assets104.40
Long-term investments6,273.20
Other Assets, Noncurrent1,615.90
Operating Lease Right Of Use Asset161.90
Total Assets10,783.10
Liabilities
Accounts Payable, Current AC133.50
Employee-related Liabilities, Current AC210.30
Notes and Loans Payable, Current LO400.90
Other Liabilities, Current125.40
Taxes Payable, Current, Total37.80
Deferred Revenue, Current DE61.20
Total Current Liabilities969.10
Long-term debt1,204.00
Capital Lease and Other400.90
Total Long-term Debt1,604.90
Financial Instruments, Insurance, Noncurrent69.00
Other liabilities, Noncurrent537.10
Operating Lease Liability Current36.20
Operating Lease Liability Noncurrent138.60
Total Liabilities3,180.10
Stockholders' Equity
Treasury Stock Value0.00
Additional Paid In Capital Common Stock470.10
Retained Earnings / Accumulated Deficit8,479.20
Accumulated Other Comprehensive Income-315.30
Other Equity-315.30
Common Stockholder's Equity7,603.00
Preferred Stockholder's Equity0.00
Total Stockholder's Equity7,603.00
Liabilities & Stockholder's Equity10,783.10
4 historic quarters locked

Sign in to unlock the full Bio rad Laboratories Inc balance sheet history.

Sign In Create Free Account

About Bio Rad Laboratories Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260930)
  • Filed with the SEC: November 4, 2026
  • Source: bio-20260930.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000012208-26-000058

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API Connect Your AI